Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203436 · ClinicalTrials.gov registry record · Phase 2
Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity
A Phase 2 study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- Phase 2
- Development phase
- 649
- Enrollment target
NCT01203436 is a Phase 2 study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 649 participants.
The verdict
NCT01203436, a Phase 2 study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 649 participants
- Enrollment target
Study Summary
The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.
Interventions
- PROCEDURE Supplemental Oxygen Management
- PROCEDURE Conventional Oxygen Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 649 participants |
| Start Date | 1994-02 |
| Est. Completion | 1999-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01203436
The ClinicalTrials.gov registry entry for NCT01203436 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 649 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supplemental Oxygen Management is the first listed.
NCT01203436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01203436 about?
NCT01203436 is a clinical study titled "Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity". The purpose of this trial was to determine the efficacy and safety of supplemental therapeutic oxygen for infants with prethreshold retinopathy of prematurity (ROP) to reduce the probability of progression to threshold ROP and the need for peripheral retinal ablation.
What is the current status of trial NCT01203436?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 649 participants. The study started on 1994-02. Estimated completion is 1999-03.
What interventions are being tested in trial NCT01203436?
The interventions under investigation include: Supplemental Oxygen Management (PROCEDURE), Conventional Oxygen Management (PROCEDURE).
Who is sponsoring clinical trial NCT01203436?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.